tetano
Editor, Senior Moderator
Lab Chip
. 2022 May 11.
doi: 10.1039/d2lc00101b. Online ahead of print.
Micro-PCR chip-based multifunctional ultrafast SARS-CoV-2 detection platform
Hao Yin[SUP] 1 2 [/SUP], Zhaoduo Tong[SUP] 1 2 [/SUP], Chuanjie Shen[SUP] 1 2 [/SUP], Xin Xu[SUP] 1 [/SUP], Hui Ma[SUP] 1 [/SUP], Zhenhua Wu[SUP] 1 [/SUP], Yong Qi[SUP] 3 [/SUP], Hongju Mao[SUP] 1 2 [/SUP]
Affiliations
Abstract
When dealing with infectious pathogens, the point-of-care screening and diagnosis strategy should be low-cost, simple, rapid and accurate. Here, we report a multifunctional rapid PCR platform allowing both simultaneous screening of suspected cases and accurate identification and quantification of the virus. Based on the platform, samples suspected of being infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are screened first, after which subsequent precise quantification of the virus (SARS-CoV-2) can be performed if necessary. This fast screening technique offers a detection limit of 10 nucleic acid copies per test during the entire running time of 15 minutes, with a throughput of 9 samples at a time. Besides, depending on a droplet microfluidic chip, this platform could also provide assays of nucleic acids across four orders of magnitude of concentration within less than 15 minutes. Additionally, we successfully use the platform to quickly distinguish between positive and negative cases in clinical samples and rapidly quantify the viral load in each sample, which is consistent with standard RT-qPCR tests. As such, we demonstrate a promising and versatile rapid PCR platform for point-of-care diagnosis of infectious diseases.
. 2022 May 11.
doi: 10.1039/d2lc00101b. Online ahead of print.
Micro-PCR chip-based multifunctional ultrafast SARS-CoV-2 detection platform
Hao Yin[SUP] 1 2 [/SUP], Zhaoduo Tong[SUP] 1 2 [/SUP], Chuanjie Shen[SUP] 1 2 [/SUP], Xin Xu[SUP] 1 [/SUP], Hui Ma[SUP] 1 [/SUP], Zhenhua Wu[SUP] 1 [/SUP], Yong Qi[SUP] 3 [/SUP], Hongju Mao[SUP] 1 2 [/SUP]
Affiliations
- PMID: 35543190
- DOI: 10.1039/d2lc00101b
Abstract
When dealing with infectious pathogens, the point-of-care screening and diagnosis strategy should be low-cost, simple, rapid and accurate. Here, we report a multifunctional rapid PCR platform allowing both simultaneous screening of suspected cases and accurate identification and quantification of the virus. Based on the platform, samples suspected of being infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are screened first, after which subsequent precise quantification of the virus (SARS-CoV-2) can be performed if necessary. This fast screening technique offers a detection limit of 10 nucleic acid copies per test during the entire running time of 15 minutes, with a throughput of 9 samples at a time. Besides, depending on a droplet microfluidic chip, this platform could also provide assays of nucleic acids across four orders of magnitude of concentration within less than 15 minutes. Additionally, we successfully use the platform to quickly distinguish between positive and negative cases in clinical samples and rapidly quantify the viral load in each sample, which is consistent with standard RT-qPCR tests. As such, we demonstrate a promising and versatile rapid PCR platform for point-of-care diagnosis of infectious diseases.